Neurana Pharmaceuticals
Latest round
- Series A
Last raised
- May 2018
Total raised
- $60M
Investors
- 5
About Neurana Pharmaceuticals
Neurana Pharmaceuticals, Inc.Neurana Pharmaceuticals, Inc. was founded in 2013 and is headquartered in San Diego, US. The company specializes in developing pharmaceutical solutions for neurological conditions.G. BioHealth Partners, Longitude Capital, MagnaSci Ventures, and New Leaf Venture Partners.Neurana Pharmaceuticals specializes in developing innovative pharmaceutical solutions aimed at addressing critical unmet medical needs, particularly for neurological disorders. Their product offerings target conditions such as Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease, providing both symptomatic relief and potential disease-modifying effects. Neurana's development process includes preclinical and clinical trials to ensure safety and efficacy prior to market release.Neurana Pharmaceuticals generates revenue through direct sales to healthcare facilities and pharmaceutical distributors, primarily for prescription medications often covered by insurance. The company engages in strategic collaborations with larger pharmaceutical firms to enhance distribution channels. Pricing is determined based on market dynamics and therapeutic value to maintain competitiveness while delivering high-quality solutions. The company aims to enter new markets in Europe and Asia by 2025 to enhance patient access to its therapies.
Who invested in Neurana Pharmaceuticals
5 investors across 1 round
See all investors in Neurana Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 3, 2018
Amount
$60M
Investors
Questions about Neurana Pharmaceuticals
Who invested in Neurana Pharmaceuticals?
Neurana Pharmaceuticals has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neurana Pharmaceuticals raised?
Neurana Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Neurana Pharmaceuticals last raise money?
Neurana Pharmaceuticals's most recent round on record is a Series A, in May 2018.
What does Neurana Pharmaceuticals do?
Neurana Pharmaceuticals is a pharmaceuticals company.
Where is Neurana Pharmaceuticals headquartered?
Neurana Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like Neurana Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Neurana Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Neurana Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.